Inicio
Resultado de la búsqueda
1 búsqueda de la palabra clave 'tannate'
Clasificado(s) por (Año de edición descendente) Refinar búsqueda Genera el flujo rss de la búsqueda
Enlace permanente de la investigación
Gelatin tannate for acute diarrhoea and gastroenteritis in children: a systematic review and meta-analysis / Laura Fernanda Niño Serna
Título : Gelatin tannate for acute diarrhoea and gastroenteritis in children: a systematic review and meta-analysis Tipo de documento : documento electrónico Autores : Laura Fernanda Niño Serna, Fecha de publicación : 2020 Títulos uniformes : Archives of Disease in Childhood Idioma : Inglés (eng) Palabras clave : Children diarrhoea gastroenteritis gelatin meta-analysis systematic review tannate Resumen : Objective: To determine the effectiveness and safety of gelatin tannate (GT) for reducing the duration of the acute diarrhoea and gastroenteritis (ADG) in children. Design: Systematic review and meta-analysis. Data sources: MEDLINE, Embase, CINAHL, Cochrane Central Register of Controlled Trials, LILACS and grey literature, published from inception to October 2018. No language restrictions. Eligibility criteria for selecting studies: Randomised controlled trials in children with ADG, comparing GT with placebo. Results: Of 797 titles identified, we included three studies (276 children). We performed a random effects model meta-analysis for the main outcome (diarrhoea duration). We did not find significant differences between GT and placebo for diarrhoea duration (mean difference (MD)=−15.85 hours; 95% CI −42.24 to 14.82, I2=92%; three studies), stool frequency at day 2 (MD=0.11 stools/day; 95% CI −0.39 to 0.62: I2=26%; two studies), diarrhoea at day 3 (risk ratio [RR]=0.46; 95% CI 0.06 to 3.47: I2=73%; two studies), vomiting (RR=1.31; 95% CI 0.95 to 1.80: I2=0%; two studies) or adverse events (RR=0.86; 95% CI 0.27 to 2.66: I2=0%; two studies). Most common adverse events included abdominal pain and nausea. Conclusion: The effect of GT was no different to placebo for mean diarrhoea duration (low certainty on the evidence) and stool frequency at day 2 (high certainty) and for the presence of diarrhoea at day 3 (very low certainty) of vomiting (moderate certainty) and of adverse events (low certainty). Mención de responsabilidad : Ivan D Florez, Javier M Sierra, Laura F Niño-Serna Referencia : Arch Dis Child. 2020 Feb;105(2):141-146. DOI (Digital Object Identifier) : 10.1136/archdischild-2018-316385 PMID : 31272969 En línea : https://adc.bmj.com/content/early/2019/07/04/archdischild-2018-316385 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4241 Gelatin tannate for acute diarrhoea and gastroenteritis in children: a systematic review and meta-analysis [documento electrónico] / Laura Fernanda Niño Serna, . - 2020.
Obra : Archives of Disease in Childhood
Idioma : Inglés (eng)
Palabras clave : Children diarrhoea gastroenteritis gelatin meta-analysis systematic review tannate Resumen : Objective: To determine the effectiveness and safety of gelatin tannate (GT) for reducing the duration of the acute diarrhoea and gastroenteritis (ADG) in children. Design: Systematic review and meta-analysis. Data sources: MEDLINE, Embase, CINAHL, Cochrane Central Register of Controlled Trials, LILACS and grey literature, published from inception to October 2018. No language restrictions. Eligibility criteria for selecting studies: Randomised controlled trials in children with ADG, comparing GT with placebo. Results: Of 797 titles identified, we included three studies (276 children). We performed a random effects model meta-analysis for the main outcome (diarrhoea duration). We did not find significant differences between GT and placebo for diarrhoea duration (mean difference (MD)=−15.85 hours; 95% CI −42.24 to 14.82, I2=92%; three studies), stool frequency at day 2 (MD=0.11 stools/day; 95% CI −0.39 to 0.62: I2=26%; two studies), diarrhoea at day 3 (risk ratio [RR]=0.46; 95% CI 0.06 to 3.47: I2=73%; two studies), vomiting (RR=1.31; 95% CI 0.95 to 1.80: I2=0%; two studies) or adverse events (RR=0.86; 95% CI 0.27 to 2.66: I2=0%; two studies). Most common adverse events included abdominal pain and nausea. Conclusion: The effect of GT was no different to placebo for mean diarrhoea duration (low certainty on the evidence) and stool frequency at day 2 (high certainty) and for the presence of diarrhoea at day 3 (very low certainty) of vomiting (moderate certainty) and of adverse events (low certainty). Mención de responsabilidad : Ivan D Florez, Javier M Sierra, Laura F Niño-Serna Referencia : Arch Dis Child. 2020 Feb;105(2):141-146. DOI (Digital Object Identifier) : 10.1136/archdischild-2018-316385 PMID : 31272969 En línea : https://adc.bmj.com/content/early/2019/07/04/archdischild-2018-316385 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4241 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD001221 AC-2019-010 Archivo digital Producción Científica Artículos científicos Disponible